You are not logged in!
Do you want to login? It's free!

Mon, 28 July 2014.
Check the latest stories & news.

Search implu: Advanced

Who do you implu?    Create a Free Account!

Patent Applications

Pub DatePub NumberApp NumberApp DateTitle
2011-02-0320110023242126796572008-09-23DICHROMOPHORE CARBONYL OR HETEROCYCLIC DYE, DYE COMPOSITION COMPRISING THIS DYE, PROCESS FOR DYEING KERATIN MATERIALS USING THIS DYE
2011-02-0320110024929129354302009-03-30APPARATUS FOR PRODUCING LIPOSOMES AND METHOD OF PRODUCING LIPOSOMES
2011-02-0320110027171124434962007-10-05PH SENSITIVE LIPOSOME COMPOSITION
2011-02-0320110027172127470402008-12-10DRUG DELIVERY SYSTEM FOR PHARMACEUTICALS AND RADIATION
2011-02-0320110027173128100952008-12-24EPHRIN TYPE-A RECEPTOR 10 PROTEIN
2011-02-0320110027174129058582010-10-15NANOTUBES FOR CANCER THERAPY AND DIAGNOSTICS
2011-02-0320110027175122808292007-02-27CANCER IMAGING AND TREATMENT
2011-02-0320110027176128440182010-07-27HOMING PEPTIDE FOR TUMOR VASCULATURE
2011-02-0320110027177129336382008-09-17INHIBITION OF ANGIOGENESIS
2011-02-0320110027178128679142009-02-26IMAGING THE CENTRAL NERVOUS SYSTEM
2011-02-0320110027179129044332010-10-14Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
2011-02-0320110027180127593222010-04-13DETECTION AND TREATMENT OF PROSTATE CANCER
2011-02-0320110027181128021482010-05-28Device including altered microorganisms, and methods and systems of use
2011-02-0320110027182128285792010-07-01SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS
2011-02-0320110027183128641972009-01-26Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver
2011-02-0320110027184121608892007-01-12PROTEIN C PATHWAY ASSOCIATED POLYMORPHISMS AS RESPONSE PREDICTORS TO ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND ADMINISTRATION
2011-02-0320110027185126676252008-07-14Methods of Screening for Anti-Angiogenic Compounds
2011-02-0320110027186126809822008-10-06TAZ/WWTR1 FOR DIAGNOSIS AND TREATMENT OF CANCER
2011-02-0320110027187127348642008-11-21THERAPEUTIC OR PROPHYLACTIC AGENT, DETECTION METHOD AND DETECTION AGENT FOR METABOLIC SYNDROME, AND METHOD FOR SCREENING OF CANDIDATE COMPOUND FOR THERAPEUTIC AGENT FOR METABOLIC SYNDROME
2011-02-0320110027188129014022010-10-08Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers
2011-02-0320110027190125997132008-06-04COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL
2011-02-0320110027192129207072009-03-09SLIM-FIT FAT BURNING WATER
2011-02-0320110027193129031202010-10-12COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
2011-02-0320110027194129034712010-10-13HYPOCHLORITE DENTURE COMPOSITIONS AND METHODS OF USE
2011-02-0320110027195125815292009-10-19COMPOSITION FOR DENTAL BARRIER COMPRISING AT LEAST ONE MONOMER, AT LEAST ONE POLYMERIZATION INITIATING SYSTEM, AND AT LEAST ONE INDICATOR ENABLING THE POLYMERIZATION REACTION TO BE MONITORED
2011-02-0320110027196125346212009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027197125346492009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027198125346822009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027199128029552010-06-17Drink container with a breath strip
2011-02-0320110027200128471772010-07-30METHODS TO STABILIZE AND PREVENT BREAKDOWN OF SUNSCREEN AND OTHER TOPICAL AND ORAL PREPARATIONS AND COMPOSITIONS PRODUCED THEREBY
2011-02-0320110027201129019112010-10-11METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
2011-02-0320110027202128088392008-11-12FLUID OIL-IN-WATER SUNSCREEN EMULSIONS CONTAINING GEMINI SURFACTANTS AND A CROSSLINKED COPOLYMER OF METHACRYLIC ACID AND OF C1-C4 ALKYL ACRYLATE
2011-02-0320110027203129019682010-10-11SYNTHESIS OF A NITROXIDE ANTIOXIDANT AND METHODS OF USE IN COSMETIC AND DERMATOLOGICAL COMPOSITIONS
2011-02-0320110027204129029722010-10-12ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
2011-02-0320110027205129374832009-04-16USE OF MYRTLE EXTRACT AS DEPIGMENTING AGENT
2011-02-0320110027206124383682009-01-22Alkyl Quaternium Silicone Compounds
2011-02-0320110027207125103292009-07-28EYELASH AND EYEBROW FORTIFIER
2011-02-0320110027208128907962010-09-27Photolabile Fragrance Storage Substances
2011-02-0320110027209129367612009-04-08Compositions Containing Cyclic Peptides And Methods Of Use
2011-02-0320110027210128669712009-01-22TWO-PART COSMETIC PRODUCT WITH SWELLING EFFECT TO BIOLOGICAL SURFACES
2011-02-0320110027211129348492009-03-13HAIR STYLING COMPOSITION
2011-02-0320110027213128446472010-07-27ORGANOPOLYSILOXANE HAVING AMIDE GROUP, AND COSMETIC MATERIAL CONTAINING SAME
2011-02-0320110027214126932612010-01-25POLYQUATERNIUM- 1 SYNTHESIS METHODS
2011-02-0320110027215129042302010-10-14PROTEIN-BASED POLYMER TISSUE ADHESIVES FOR MEDICAL USE
2011-02-0320110027216129042252010-10-14PROTEIN-BASED POLYMER TISSUE ADHESIVES FOR MEDICAL USE
2011-02-0320110027217127882662010-05-26IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
2011-02-0320110027218124394862007-08-28TNF SUPERFAMILY FUSION PROTEINS
2011-02-0320110027219128047952010-07-29Treatment of Crohn's disease with laquinimod
2011-02-0320110027220119927312006-09-28Interleukin-1 Conjugates and Uses Thereof
2011-02-0320110027221125299812008-09-24Skincare Composition Comprising HSA Fusion Protein, Preparation Method And Uses Thereof
2011-02-0320110027222126778992008-09-24Vaccine for the Treatment of Osteoarthritis
2011-02-0320110027223127389492008-10-29USE OF ELECTROPHILIC COMPOUNDS FOR INDUCING PLATELET PRODUCTION OR MAINTAINING PLATELET FUNCTION
2011-02-0320110027224128878432010-09-22USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA
2011-02-0320110027225129002822010-10-07MN/CA IX and EGFR Pathway Inhibition
2011-02-0320110027226126741192007-08-22INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5)
2011-02-0320110027227127353922009-01-14ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION
2011-02-0320110027228129051492010-10-15USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
2011-02-0320110027229128488562010-08-02CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-ALPHA TO HEPATITIS C INFECTED PATIENTS
2011-02-0320110027230128674342009-02-20COMPOSITIONS COMPRISING PHYTOESTROGENES SELECTIVE FOR ESTROGEN BETA RECEPTOR AND DIETARY FIBRES
2011-02-0320110027231125207892007-12-18METHOD FOR THE RANDOM DIVERSIFICATION OF A GENETIC SEQUENCE WHILE PRESERVING THE IDENTITY OF SOME INNER SEGMENTS OF SAID GENETIC SEQUENCE
2011-02-0320110027234124507642008-04-10METHODS FOR IDENTIFICATION AND SELECTION OF HUMAN EMBRYONIC STEM CELL DERIVED CELLS
2011-02-0320110027235127987492010-04-08Targeted integration into stem cells
2011-02-0320110027236128677192009-02-16PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOARTICULAR DISEASES
2011-02-0320110027237129054362010-10-15Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
2011-02-0320110027238129081192010-10-20Mesenchymal Stem Cells and Uses Therefor
2011-02-0320110027239125119402009-07-29ADIPOSE-DERIVED STROMAL CELLS (ASC) AS DELIVERY TOOL FOR TREATMENT OF CANCER
2011-02-0320110027240128119322009-01-09SECRETABLE HIV ENTRY INHIBITORY PEPTIDES FOR THERAPY OF HIV INFECTION
2011-02-0320110027241129052532010-10-15Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
2011-02-0320110027242129348432009-03-27METHOD FOR PRODUCTION OF TRANSFECTED CELL
2011-02-0320110027243127454412008-12-03COMPOSITION BASED ON PROBIOTIC BACTERIA IN ASSOCIATION WITH A PREBIOTIC AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES AND/OR INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY
2011-02-0320110027244128445162010-07-27Compositions and methods of preparing alloreactive cytotoxic T cells
2011-02-0320110027245128446682010-07-27Pairing processes for preparing alloreactive cytotoxic T cells
2011-02-0320110027246125644782009-09-22NOVEL BACILLUS THURINGIENSIS STRAIN FOR INHIBITING INSECT PESTS
2011-02-0320110027247127780942010-05-11METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
2011-02-0320110027248128099692008-12-26Sugar Chain-Related Gene and Use Thereof
2011-02-0320110027249127846752010-05-21Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens
2011-02-0320110027250128459492010-07-29Sealants for Fetal Membrane Repair
2011-02-0320110027251129219332009-03-06NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
2011-02-0320110027253126685172008-07-09PADLOCK PROBE AMPLIFICATION METHODS
2011-02-0320110027254128456532010-07-28COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE
2011-02-0320110027255129051352010-10-15Composition and Method for Treating Papilloma Virus and Equine Sarcoids
2011-02-0320110027256128629482010-08-25FUSION PROTEINS
2011-02-0320110027257127442002009-01-07CLOTTABLE CONCENTRATE OF PLATELET GROWTH FACTORS AND PREPARATION METHOD THEREOF
2011-02-0320110027258128775532010-09-08MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
2011-02-0320110027259129029942010-10-12COMPONENT OF BROMELAIN
2011-02-0320110027260126467472009-12-23BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
2011-02-0320110027261128721722010-08-31ANTI-HEPCIDIN ANTIBODIES AND USES THEREOF
2011-02-0320110027262128799162010-09-10PLATFORM ANTIBODY COMPOSITIONS
2011-02-0320110027263128997002010-10-07SOLUBLE INTERLEUKIN-20 RECEPTOR
2011-02-0320110027264129195742009-02-26GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
2011-02-0320110027265126755972008-08-29Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions
2011-02-0320110027266126757992008-08-27Humanized anti-CXCR5 antibodies, derivatives thereof and their use
2011-02-0320110027267127417022008-11-10Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
2011-02-0320110027268127448492008-11-19ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF
2011-02-0320110027269127452292008-11-2614-3-3 Antagonists for the Prevention and Treatment of Arthritis
2011-02-0320110027270127881032010-05-26MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF
2011-02-0320110027271128169182010-06-16ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION
2011-02-0320110027272128170972010-06-16STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
2011-02-0320110027273128218162010-06-23IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS
2011-02-0320110027274128464932010-07-29ANTIPROLIFERATIVE COMPOUNDS, CONJUGATES THEREOF, METHODS THEREFOR, AND USES THEREOF
2011-02-0320110027275128471632010-07-30INHIBITION OF TUMOR METASTASIS
2011-02-0320110027276128640752009-01-21Optimized CD40 Antibodies and Methods of Using the Same
2011-02-0320110027277129358122009-03-31PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORS
2011-02-0320110027278127323712010-03-26REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF
2011-02-0320110027279126910462010-01-21RECOMBINANT ANTIBODIES SPECIFIC FOR BETA-AMYLOID ENDS, DNA ENCODING AND METHODS OF USE THEREOF
2011-02-0320110027280128375882010-07-16Methods For Inducing Autolysis In Infectious Bacteria
2011-02-0320110027281129055892010-10-15SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
2011-02-0320110027282123104322007-08-23INTERFERON ANTAGONISTS, ANTIBODIES THERETO AND ASSOCIATED METHODS OF USE
2011-02-0320110027283126768172008-09-05METHODS FOR DIAGNOSING AND TREATING CANCERS
2011-02-0320110027284127407772008-10-27NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF
2011-02-0320110027285127546262010-04-06METHODS AND AGENTS MODULATING UPA/UPAR ACTIVITY
2011-02-0320110027286128439052010-07-27High Affinity Human Antibodies to Human Angiopoietin-2
2011-02-0320110027287129030842010-10-12ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
2011-02-0320110027288129347732009-03-24HUMAN MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN, AND THEIR USE AS THERAPEUTIC AGENTS
2011-02-0320110027289127695992010-04-28METHOD FOR TREATING SYNOVIAL SARCOMA
2011-02-0320110027290129088922010-10-21ANTI-IL-17 ANTIBODIES
2011-02-0320110027291127075212010-02-17METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE
2011-02-0320110027292128399332010-07-20Protein Formulations with Reduced Viscosity and Uses Thereof
2011-02-0320110027293126447992009-12-22METHODS AND COMPOSITIONS FOR THE INHIBITION OF VIRAL INFECTION BY TARGETING INTRACELLULAR TRAFFICKING
2011-02-0320110027294129009242010-10-08Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
2011-02-0320110027295126767412008-09-08Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses
2011-02-0320110027296129358382009-04-08ANTIBODIES FOR TREATING CANCER
2011-02-0320110027297129371782009-03-30Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
2011-02-0320110027298128437392010-07-26MICROBIAL DELIVERY SYSTEM
2011-02-0320110027299128517292010-08-06MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
2011-02-0320110027300128670562009-02-13Identification of a novel cysteine-rich cell penetrating peptide
2011-02-0320110027301128870322010-09-21EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
2011-02-0320110027302129039612010-10-13PEPTIDE VACCINES FOR LUNG CANCERS EXPRESSING TTK, URLC10 OR KOC1 POLYPEPTIDES
2011-02-0320110027303129357612009-03-31PARTIAL PEPTIDE OF SURVIVIN PRESENTED ON MHC CLASS II MOLECULE AND USE THEROF
2011-02-0320110027304126682582008-07-11YERSINIA PESTIS ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
2011-02-0320110027305128485682010-08-02Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus
2011-02-0320110027306128310172010-07-06TC-83-Derived Alphavirus Vectors, Particles and Methods
2011-02-0320110027307127853122010-05-21ANTI-SEPSIS CONJUGATE VACCINE
2011-02-0320110027308126760792008-09-09COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES
2011-02-0320110027309124418512007-09-18COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES
2011-02-0320110027310125988742008-05-05Compositions and Methods for Cancer Treatment
2011-02-0320110027311128440442010-07-27COMBINATION OF PROTEIN VACCINE AND MESENCHYMAL STEM CELLS FOR TREATING CANCER
2011-02-0320110027312129371812009-04-08CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
2011-02-0320110027313129361652009-04-06VIRAL RECOMBINEERING AND USES THEREOF
2011-02-0320110027314122232082007-01-26Influenza Vaccines Containing Hemagglutinin and Matrix Proteins
2011-02-0320110027315126767972008-09-05PROTEIN CAGES AND THEIR USES
2011-02-0320110027316127441362008-11-21BLUETONGUE VIRUS VACCINE AND IMMUNOGENIC COMPOSITIONS, METHODS OF USE AND METHODS OF PRODUCING SAME
2011-02-0320110027317128042422010-07-16Production of poliovirus at high titers for vaccine production
2011-02-0320110027318124100832009-03-24NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS
2011-02-0320110027319127834912010-05-19METHODS OF ELICITING OR BOOSTING A CELLULAR IMMUNE RESPONSE
2011-02-0320110027321126014312008-05-23Chlamydia Vaccine Comprising HtrA Polypeptides
2011-02-0320110027322125455602009-08-21TUMOR VACCINE, A METHOD FOR PRODUCING A TUMOR VACCINE AND A METHOD FOR CARRYING OUT ANTITUMOR IMMUNOTHERAPY
2011-02-0320110027323128504282010-08-04ADJUVANTS AND METHODS OF USE
2011-02-0320110027324127470962007-12-10O-DESMETHYL-VENLAFAXINE FOR TREATING MAJOR DEPRESSIVE DISORDER
2011-02-0320110027325129348192009-03-09ORALLY-ADMINISTERED AGENT
2011-02-0320110027326129354972009-03-26External Composition for Skin
2011-02-0320110027327126739192008-10-01COSMETIC OR PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
2011-02-0320110027328128468622010-07-30Oral Care Articles and Methods
2011-02-0320110027329127845972010-05-21Single-use, Disposable Strip For Application Of Topical Compositions
2011-02-0320110027331125115242009-07-29AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION
2011-02-0320110027335126728442008-08-11COATED MEDICAL DEVICES
2011-02-0320110027338129002162010-10-07BIOLOGIC REPLACEMENT FOR FIBRIN CLOT
2011-02-0320110027340125338582009-07-31IMPLANTABLE DRUG DEPOT FOR WEIGHT CONTROL
2011-02-0320110027342128455552010-07-28S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY
2011-02-0320110027344126481072009-12-28Alginate-Containing Wound Dressing, Method and Apparatus for Making the Same
2011-02-0320110027345126679152008-07-03COMPOSITION CONTAINING ROTIGOTINE AND USE THEREOF AND TRANSDERMAL PATCH CONTAINING THE COMPOSITION
2011-02-0320110027346123030882007-05-29Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them
2011-02-0320110027347125105412009-07-28POLYMERSOMES AND METHODS OF MAKING AND USING THEREOF
2011-02-0320110027348126755042007-08-27COMPOSITION AND METHOD INHIBITING INFLAMMATION
2011-02-0320110027349128125412009-01-12POLYPEPTIDE VACCINE AND VACCINATION STRATEGY AGAINST MYCOBACTERIUM
2011-02-0320110027350128432842010-07-26GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS
2011-02-0320110027351129032662010-10-13LIPOSOMAL FORMULATIONS COMPRISING AN AMPHIPATHIC WEAK BASE LIKE TEMPAMINE FOR TREATMENT OF NEURODEGENERATIVE CONDITIONS
2011-02-0320110027352128633802009-01-16COMPOUNDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
2011-02-0320110027353129025942010-10-12Therapeutic Delivery System
2011-02-0320110027354129356732009-03-31ANTI-PARKINSONIAN COMPOUNDS
2011-02-0320110027355129365782009-04-07HIGH-FLUIDITY AND NON-CAKING PULVERULENT CRYSTALLINE MALTITOL COMPOSITION
2011-02-0320110027356128643972009-01-26Combination of Oral Medicaments Bonded by a Wrapping
2011-02-0320110027357129005992010-10-08Compositions and methods for timed release of water-soluble nutritional supplements
2011-02-0320110027358125325352008-03-31VALSARTAN TABLET FORMULATIONS
2011-02-0320110027359127207682010-03-10Novel Pharmaceutical Compositions Comprising Levetiracetam
2011-02-0320110027360128456002010-07-28PHARMACOKINETICS OF S-ADENOSYLMETHIONINE FORMULATIONS
2011-02-0320110027361128658012009-02-03EXTENDED RELEASE DOSAGE FORM OF PALIPERIDONE
2011-02-0320110027362128669992009-02-10TABLET HAVING IMPROVED ELUTION PROPERTIES
2011-02-0320110027363125914472009-11-19Nouvelle forme d'administration de proteines osteogeniques
2011-02-0320110027364127448482008-11-26BIOACTIVE AND RESORBABLE SOYBEAN-BASED BIOMATERIALS
2011-02-0320110027365128311902010-07-06Patch Formulation For External Use
2011-02-0320110027366129027102010-10-12SKIN EQUIVALENT CULTURE
2011-02-0320110027367129029312010-10-12ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
2011-02-0320110027368129051862010-10-15POLYMERIC COMPOSITIONS COMPRISING THERAPEUTIC AGENTS IN CRYSTALLINE PHASES, AND METHODS OF FORMING THE SAME
2011-02-0320110027369128588832010-08-18PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS
2011-02-0320110027370129055672010-10-15Sustained Drug Release Composition
2011-02-0320110027371113677162006-03-06Nanoparticulate statin formulations and novel statin combinations
2011-02-0320110027372129020332010-10-11MULTIPARTICULATES COMPRISING LOW-SOLUBILITY DRUGS AND CARRIERS THAT RESULT IN RAPID DRUG RELEASE
2011-02-0320110027373125262392008-02-07METHODS AND COMPOSITIONS FOR MODULATING SIALIC ACID PRODUCTION AND TREATING HEREDITARY INCLUSION BODY MYOPATHY
2011-02-0320110027374126199182009-11-17CAPECITABINE RAPIDLY DISINTEGRATING TABLETS
2011-02-0320110027375127381912008-10-14USE OF LANTHANIDE-BASED NANOPARTICLES AS RADIOSENSITIZING AGENTS
2011-02-0320110027376127476392008-12-02Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
2011-02-0320110027377128157152010-06-15IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM
2011-02-0320110027378129020172010-10-11PROCESS OF MAKING FLOWABLE HEMOSTATIC COMPOSITIONS AND DEVICES CONTAINING SUCH COMPOSITIONS
2011-02-0320110027379127465002008-12-04Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use
2011-02-0320110027381124456352007-10-16TREATMENT OF OSTEOPOROSIS
2011-02-0320110027382128035432010-06-29Solubilized benzoyl peroxyde acne
2011-02-0320110027384129361262009-04-06PHOTOSENSITISING COMPOSITION AND ITS USES
2011-02-0320110027385127442252008-11-21NANO-PARTICLE DISPERSIONS
2011-02-0320110027387126607222010-03-03Nutritional supplement for use with poultry and livestock and method of using
2011-02-0320110027388128473422010-07-30Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus
2011-02-0320110027389128126702009-01-13Low Viscosity Liquid Polymeric Delivery System
2011-02-0320110027390129039342010-10-13Methods for Reducing Cisplatin Nephrotoxicity
2011-02-0320110027391128094182008-03-04LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT
2011-02-0320110027393125975482008-04-30HUMAN DIABETES SUSCEPTIBILITY EEFSEC GENE
2011-02-0320110027394128091852008-12-22Cross-Linked Biopolymers, Related Compounds and Methods of Use
2011-02-0320110027396128101782008-12-23NOVEL MILK THISTLE EXTRACT, METHOD FOR THE PRODUCTION, AND USE
2011-02-0320110027397125345712009-08-03METHODS OF TREATING AUTISM SPECTRUM DISORDERS AND COMPOSITIONS FOR SAME
2011-02-0320110027398126740442008-08-19METHODS OF MAKING OLIVE JUICE EXTRACTS CONTAINING REDUCED SOLIDS
2011-02-0320110027399129354732009-03-31Antiviral Agent and Antiviral Composition
2011-02-0320110027455127665092010-04-23SEQUESTERING SUBUNIT AND RELATED COMPOSITIONS AND METHODS
2011-02-0320110028367129034182010-10-13PHOTO-LABILE PRO-FRAGRANCE CONJUGATES
2011-02-0320110028368129043092010-10-14HYPOCHLORITE DENTURE COMPOSITIONS AND METHODS OF USE
2011-02-0320110028382127433632008-10-07TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA
2011-02-0320110028383127891482010-05-27Activated Forms Of Notch And Methods Based Thereon
2011-02-0320110028385128663252009-01-27Combination of Immunomodulator and Anti-Pathogenic Agent
2011-02-0320110028387127550462010-04-06METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
2011-02-0320110028388129361642008-04-03DOUBLE-STRANDED POLYETHYLENE GLYCOL MODIFIED GROWTH HORMONE, PREPARATION METHOD AND APPLICATION THEREOF
2011-02-0320110028389129010482010-10-08USE OF INFANT FORMULA WITH REDUCED PROTEIN CONTENT
2011-02-0320110028390129343752009-05-18Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
2011-02-0320110028391129053242010-10-15Use of GLP-1 Peptides
2011-02-0320110028392129011782010-10-08METHODS FOR USE OF BRANCHED AMINO ACIDS
2011-02-0320110028393125126512009-07-30FLOWABLE PASTE AND PUTTY BONE VOID FILLER
2011-02-0320110028394128467242010-07-29THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
2011-02-0320110028395125220422008-01-03PEPTIDE MODULATORS OF ANGIOGENESIS AND USE THEREOF
2011-02-0320110028396129355512009-03-30MEDICAL COMPOSITION
2011-02-0320110028397127451652008-12-01Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders
2011-02-0320110028398123058852007-07-10METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS
2011-02-0320110028399129880762009-04-15CITRULLINATED CYTOKINES
2011-02-0320110028400129358182009-03-26SULFATED UNSATURATED DISACCHARIDIC CHONDROITIN SULFATE IN CONNECTIVE TISSUE PROTECTION AND REPAIR
2011-02-0320110028401128454602010-07-28CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF
2011-02-0320110028402128201282010-06-21SUBSTANCE P-SAPORIN (SP-SAP) CONJUGATES AND METHODS OF USE
2011-02-0320110028403127233882010-03-12HSP70-Based Treatment for Autoimmune Diseases and Cancer
2011-02-0320110028404129360552009-03-19Composition Comprising Vegetable Peptone for Promoting Stem Cell Proliferation
2011-02-0320110028405128095852008-12-17SULFAMIDES AS ZAP-70 INHIBITORS
2011-02-0320110028406129038592010-10-13Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant
2011-02-0320110028407125263252008-02-08ENHANCEMENT OF INNATE RESISTANCE TO INFECTION
2011-02-0320110028408127408052008-10-31 DIAGNOSTIC MOLECULE AND THERAPEUTIC TARGET
2011-02-0320110028409128421972010-07-23DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES
2011-02-0320110028410117549172007-05-29Use of Amygdalin Analogues for the Treatment of Psoriasis
2011-02-0320110028411124464312007-10-18ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
2011-02-0320110028412128049722010-08-03Herbal enhanced analgesic formulations
2011-02-0320110028413129039502010-10-13Methods of Reducing Methotrexate Nephrotoxicity
2011-02-0320110028414129365392009-03-17GLUCOPYRANOSIDE DERIVATIVES
2011-02-0320110028415127466302008-12-04USE OF 3-(INDOLYL)- OR 3-(AZAINDOLYL)-4-ARYLMALEIMIDE DERIVATIVES IN LEUKENIA MANAGEMENT
2011-02-0320110028416129191572008-02-25NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH COMPRISING EXTRACTS OF FOR EXAMPLE ROSEMARY OR CARAWAY
2011-02-0320110028417128477402010-07-30Macrocyclic Compounds and Methods of Use Thereof
2011-02-0320110028418129220442009-03-12USE OF GABBA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS
2011-02-0320110028420129367332009-04-07Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors
2011-02-0320110028421127982672010-03-31Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
2011-02-0320110028422128098052008-12-18COMBINATION OF NILOTINIB AND A NITROGEN MUSTARD ANALOGUE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
2011-02-0320110028424128440112010-07-27OIL-IN-WATER MICROEMULSION CARRYING LARGE AMOUNT OF OIL
2011-02-0320110028425129359182009-04-09Vesicle And Cosmetic Containing The Same
2011-02-0320110028426125104782009-07-28DEWATERING BIOMASS MATERIAL COMPRISING POLYSACCHARIDE, METHOD FOR EXTRACTING POLYSACCHARIDE FROM BIOMASS MATERIAL, AND DEWATERED BIOMASS MATERIAL
2011-02-0320110028427127461062008-12-04DIETARY FIBER AND METHOD FOR PREPARING DIETARY FIBER
2011-02-0320110028428127506552010-03-30HIRSUTELLA SINENSIS MYCELIA COMPOSITIONS AND METHODS FOR TREATING SEPSIS AND RELATED INFLAMMATORY RESPONSES
2011-02-0320110028429127506272010-03-30COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA
2011-02-0320110028430128764742010-09-07INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND
2011-02-0320110028431128368102010-07-15ORAL MUCOADHESIVE DOSAGE FORM
2011-02-0320110028432128462412010-07-29USE OF CYCLODEXTRIN FOR TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES
2011-02-0320110028433129347332009-03-26QUINAZOLINONE DERIVATIVES AS TUBULIN POLYMERIZATION INHIBITORS
2011-02-0320110028435128475682010-07-30CRYSTALLIZATION METHOD AND BIOAVAILABILITY
2011-02-0320110028436129334192009-03-19ORAL COMBINATION OF VITAMINS
2011-02-0320110028437128562912010-08-13PHOSPHORYLATED PYRONE ANALOGS AND METHODS
2011-02-0320110028438127347852008-12-03MEDICAL USE OF 3-2,2,2-TRIMETHYLHYDRAZINIUM PROPIONATE SALTS.
2011-02-0320110028439128043412010-07-20Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
2011-02-0320110028440129358772009-03-26Simultaneous Method for the Preparation of a Mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
2011-02-0320110028441127384122008-10-13NOVEL PHENYL-SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES
2011-02-0320110028442129191342009-02-27DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
2011-02-0320110028444129360882009-04-02PHARMACEUTICALLY ACCEPTABLE SALTS OF ANTI-INFECTION QUINOLONE COMPOUNDS
2011-02-0320110028445128661252009-02-10Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
2011-02-0320110028446129005422010-10-08ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS
2011-02-0320110028447129189142009-02-26INDAZOLE DERIVATIVES
2011-02-0320110028448129205692009-03-03PYRIDINE COMPOUNDS
2011-02-0320110028449129205742009-03-03NOVEL AMINOMETHYL BENZENE DERIVATIVES
2011-02-0320110028450128440072010-07-27Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines
2011-02-0320110028451128458132010-07-29Dihydrobenzoindazoles
2011-02-0320110028452128945252010-09-30PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS
2011-02-0320110028453128439612010-07-27Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1
2011-02-0320110028454127956452010-06-07DEUTERIUM-ENRICHED BAZEDOXIFENE
2011-02-0320110028455127468552008-12-12Indole-substituted 3-cyanopyridines As Kinase Inhibitors
2011-02-0320110028456128124322009-01-12Solid Pharmaceutical Dosage Form
2011-02-0320110028457129362222009-04-01PHARMACEUTICAL PREPARATION COMPRISING PERMETHYLATED CYCLODEXTRIN
2011-02-0320110028458129371012009-04-09INHIBITION OF CELL MIGRATION BY A FARNESYLATED DIBENZODIAZEPINONE
2011-02-0320110028459128993652010-10-06Wound Healing
2011-02-0320110028460128487922010-08-02TOPICAL FORMULATION
2011-02-0320110028461129362752009-03-23HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
2011-02-0320110028462119920692006-09-15Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment
2011-02-0320110028463126674922008-07-02AMIDE COMPOUNDS
2011-02-0320110028464127431382008-11-03INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
2011-02-0320110028465128119722009-01-09AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
2011-02-0320110028466128474592010-07-30NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES
2011-02-0320110028467129354782009-03-31HETEROCYCLIC DERIVATIVES
2011-02-0320110028468129366932009-04-20COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
2011-02-0320110028469126807632008-09-24Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor
2011-02-0320110028470126740182008-07-31Detection and Treatment of Schizophrenia
2011-02-0320110028471129186502009-02-20COMBINATION THERAPY 238
2011-02-0320110028472129370312009-03-23THIENOPYRIMIDINES
2011-02-0320110028473128337332010-07-09METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS BY ADMINISTERING 6,7-DIALKOXY QUINAZOLINE DERIVATIVES
2011-02-0320110028474128540942010-08-10PROTEIN KINASE AND PHOSPHATASE INHIBITORS
2011-02-0320110028475129010632010-10-08TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS
2011-02-0320110028476128739712010-09-01PROTON PUMP INHIBITORS
2011-02-0320110028477129366402008-11-07STABLE OPHTHALMIC FORMULATIONS
2011-02-0320110028478127826502010-05-18ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
2011-02-0320110028479127406802008-10-16SUBSTITUTED PYRROLOTRIAZINES AND THEIR USE
2011-02-0320110028480129357962008-04-01ORODISPERSABLE FORMULATIONS OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITORS
2011-02-0320110028481129362212009-04-02HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
2011-02-0320110028482127826552010-05-18ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
2011-02-0320110028483128576172010-08-17INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, AND 1,2-BENZISOTHIAZOLES, AND PREPARATION AND USES THEREOF
2011-02-0320110028484129366642009-04-092-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
2011-02-0320110028485128834282010-09-161,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS
2011-02-0320110028486129364312009-04-16INDOLES AS MODULATORS OF NICOTICIC ACETYLCHOLINE RECEPTOR SUBTYPE ALPHA-7
2011-02-0320110028487127340422009-07-02IMIDAZOPYRIMIDINES AND USES THEREOF
2011-02-0320110028488127149972010-03-01COMBINATION PRODUCT COMPRISING SRC KINASE INHIBITOR AZDO530 AND AN ANTIOESTROGEN OR EGFR-TK-INHIBITOR
2011-02-0320110028489128568792010-08-16Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders
2011-02-0320110028490128122722009-01-214-PHENYL-PIPERAZIN-1-YL-ALKYL-BENZOIMIDAZOL-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE IN-HIBITORS
2011-02-0320110028491128643952009-01-23APOPTOSIS INHIBITOR
2011-02-0320110028492128434942010-07-26Heteroaryl Compounds and Their Uses
2011-02-0320110028493129362912009-04-03HETEROCYCLIC DERIVATIVE AND USE THEREOF
2011-02-0320110028494119898862006-07-28HCV NS3 Protease Inhibitors
2011-02-0320110028495128095722008-12-11THE USE OF 6-HALOGENO-[1,2,4]-TRIAZOLO-[1,5-a]-PYRIMIDINE COMPOUNDS FOR COMBATING PESTS IN AND ON ANIMALS
2011-02-0320110028496128049702010-08-03Deuterium-enriched pyrimidine compounds and derivatives
2011-02-0320110028497124504772008-03-30NOVEL DERIVATIVES OF PURINIC AND PYRIMIDINIC ANTIVIRAL AGENTS AND USE THEREOF AS POTENT ANTICANCER AGENTS
2011-02-0320110028498124383062007-09-06METHOD FOR EVALUATING PATIENTS FOR TREATMENT WITH DRUGS TARGETING RET RECEPTOR TYROSINE KINASE
2011-02-0320110028499128954722010-09-30PHARMACEUTICAL COMBINATION COMPRISING VITAMIN K
2011-02-0320110028501129363132009-03-26SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
2011-02-0320110028502128471292010-07-30DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS
2011-02-0320110028503128456552010-07-28COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
2011-02-0320110028504119894682006-07-28Formulation of radioprotective alpha beta unsaturated aryl sulfones
2011-02-0320110028505129031312010-10-12COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS
2011-02-0320110028506126667852008-06-30Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives
2011-02-0320110028507126727852008-08-08PYRIDINE DERIVATIVES AND METHODS OF USE THEREOF
2011-02-0320110028508128102312009-01-09NOVEL PROCESS FOR THE PREPARATION OF SCOPINE ESTERS
2011-02-0320110028509129370742009-04-08Sulfonamides
2011-02-0320110028510127080762010-02-18Compositions, Methods, and Kits for Treating Influenza Viral Infections
2011-02-0320110028511128439082010-07-27PROCESS FOR THE MANUFACTURE OF PHARMACEUTICALLY ACTIVE COMPOUNDS
2011-02-0320110028512129007792010-10-08BIS-HETEROCYCLIC IMIDAZOLYL COMPOUNDS
2011-02-0320110028513129349882009-03-31METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
2011-02-0320110028514127725522010-05-03Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
2011-02-0320110028515128420622010-07-23NEW PIPERIDINE DERIVATIVES
2011-02-0320110028516129046752010-10-14STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS
2011-02-0320110028517129366982009-04-074-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXAMIDE USEFUL AS A CANNABINOID CB1 NEUTRAL ANTAGONIST
2011-02-0320110028518129218732009-03-18DEXLANSOPRAZOLE PROCESS AND POLYMORPHS
2011-02-0320110028519129017072010-10-11SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES
2011-02-0320110028520129355932009-04-021,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS
2011-02-0320110028522129210492009-03-03FULLERENE THERAPIES FOR INFLAMMATION
2011-02-0320110028523128284292010-07-01Selective Alpha 2B/2C Agonists
2011-02-0320110028524129021862010-10-12PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS
2011-02-0320110028526129191652009-02-27VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS
2011-02-0320110028527128458682010-07-29Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma
2011-02-0320110028529127182082010-03-05NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471
2011-02-0320110028530127184272010-03-05NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471
2011-02-0320110028531127362302009-03-17NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801
2011-02-0320110028532128025272010-06-07Methods of treating eye diseases in diabetic patients
2011-02-0320110028533128664032009-02-05NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE
2011-02-0320110028534129010192010-10-08RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
2011-02-0320110028535129040542010-10-13OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
2011-02-0320110028536123774982007-08-16METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
2011-02-0320110028537127270612010-03-18SOMATIC CELL REPROGRAMMING
2011-02-0320110028538128425692010-07-23METHODS AND COMPOSITIONS RELATED TO TR4 LIGAND
2011-02-0320110028539128073092010-04-09Biologically active taxane analogs and methods of treatment
2011-02-0320110028540128120672009-01-09SYNTHESIS OF MACROCYCLIC CANCER CHEMOTHERAPY AGENTS AND METHODS OF USE
2011-02-0320110028541129358592008-05-15LUBIPROSTONE CRYSTAL, THE USE AND THE METHOD FOR THE PREPARATION THEREOF
2011-02-0320110028542126024062008-05-06COMPOSITIONS FOR PREVENTION OR TREATMENT OF ANOREXIA-CACHEXIA SYNDROME AND USES THEREOF
2011-02-0320110028543126591242010-02-25Formulations and methods of using nitric oxide mimetics in cancer treatment
2011-02-0320110028544129049602010-10-14CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE
2011-02-0320110028547127422452008-05-27NOVEL USE OF CAPSIATE OR DIHYDROCAPSIDATE
2011-02-0320110028548129013062010-10-08BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW
2011-02-0320110028549125995782008-05-09USE OF A MONOTERPENE TO TREAT OR PREVENT STRESS
2011-02-0320110028551129880262009-04-15NOVEL PROCESS FOR THE PREPARATION OF SODIUM GAMMA-HYDROXYBUTYRATE
2011-02-0320110028552128230662010-06-24MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF
2011-02-0320110028553126464992009-12-23TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028554126001092008-05-16 PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE
2011-02-0320110028555128988252010-10-06Antiinflammatory and Analgesic Preparation for External Use
2011-02-0320110028556125709122009-09-30TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028557126995952010-02-03TREATING PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028558128309912010-07-06TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028559126679702008-06-20SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
2011-02-0320110028560128107582008-12-17SELF-EMULSIFIABLE LIQUID FLORFENICOL COMPOSITION INTENDED TO BE INCORPORATED INTO THE DRINKING WATER OF LIVESTOCK
2011-02-0320110028561128679312009-02-23PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM
2011-02-0320110028562128638812009-01-19DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE
2011-02-0320110028564127102032010-02-22COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
2011-02-0320110028565128868872010-09-21EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT
2011-02-0320110028566127791642010-05-13COMPOSITIONS AND PRODUCTS CONTAINING CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS AND METHODS OF USING THE COMPOSITIONS AND PRODUCTS
2011-02-0320110028567129023652010-10-12SMOOTH MUSCLE CONTRACTION INHIBITORS
2011-02-0320110028568129185912009-02-18PREPARATION FOR MAGNESIUM AMMONIUM PHOSPHATE CEMENTS
2011-02-0320110028570125123012009-07-30SELF EMULSIFYING GRANULES AND PROCESS FOR THE PREPARATION OF EMULSIONS THEREFROM
2011-02-0320110028571126967652010-01-29SILICONE-MODIFIED WAX-CONTAINING COMPOSITION AND COSMETIC PREPARATION CONTAINING THE COMPOSITION
2011-02-0320110028589126780682008-09-12DENTAL POLYMERIZABLE COMPOSITION AND KIT THEREFOR
2011-02-0320110030073127455362008-11-28THERAPEUTIC TARGETS AND MEDICAMENTS INVOLVING P230/GOLGIN-245